Investigation of brain-derived neurotrophic factor as a diagnostic marker of neuroplasticity in children with motor disorder delay

  • Received 19.06.2025

  • Revised 23.10.2025

  • Accepted 25.11.2025



  • 463 Views

  • Retrieved from Volume 7, No. 4, 2025

  • Pages 27-36

The relevance of researching biomarkers of neuroplasticity lies in the growing prevalence of motor disorders in children, as timely diagnosis and early intervention are critical for improving prognosis. The aim of the study was to evaluate the diagnostic significance of brain-derived neurotrophic factor levels as a potential marker of neuroplasticity in children aged 7-8 months with motor development delay through an integrated analysis of gestational age, body weight, motor skills according to the Alberta Infant Motor Scale, and brain-derived neurotrophic factor concentration. The study involved 25 healthy children aged 7-8 months without motor disorders and 56 children of the same age with motor development delay, including 28 children who were born full-term but had motor disorders and 28 children who were born prematurely with motor disorders. The study found a significant correlation between the level of brain-derived neurotrophic factor in blood serum and the degree of motor development impairment in children. Median levels of brain-derived neurotrophic factor were highest in the control group (22.76 pg/mL) and progressively decreased in groups with motor development disorders (11.25 pg/mL and 8.30 pg/mL). Statistically significant differences in serum brainderived neurotrophic factor levels were found between all study groups (p < 0.00001). The results indicated that children with motor development disorders had significantly lower levels of brain-derived neurotrophic factor than their healthy peers, which may indicate reduced neuroplasticity in these groups. These results highlighted the potential of brainderived neurotrophic factor as an objective criterion for early diagnosis, prognosis, and evaluation of the effectiveness of rehabilitation interventions in children with motor development delays

biomarker of motor disorders; early diagnosis; full-term infants; preterm infants; Alberta Infant Motor Scale

https://doi.org/10.63341/bmbr/4.2025.27
  1. Olusanya BO, Storbeck C, Cheung VG, Hadders-Algra M. Disabilities in early childhood: A global health perspective. Children. 2023;10(1):155. DOI: 10.3390/children10010155
  2. Stansberry WM, Pierchala BA. Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis. Front Mol Neurosci. 2023;16:1238453. DOI: 10.3389/fnmol.2023.1238453
  3. Treble-Barna A, Petersen BA, Stec Z, Conley YP, Fink EL, Kochanek PM. Brain-derived neurotrophic factor in pediatric acquired brain injury and recovery. Biomolecules. 2024;14(2):191. DOI: 10.3390/biom14020191
  4. Song Q, E S, Zhang Z, Liang Y. Neuroplasticity in the transition from acute to chronic pain. Neurotherapeutics. 2024;21(6):e00464. DOI: 10.1016/j.neurot.2024.e00464
  5. Xiong HY, Hendrix J, Schabrun S, Wyns A, Campenhout JV, Nijs J, et al. The role of the brain-derived neurotrophic factor in chronic pain: Links to central sensitization and neuroinflammation. Biomolecules. 2024;14(1):71. DOI: 10.3390/biom14010071
  6. Barbosa AG, Pratesi R, Paz GSC, Dos Santos MAAL, Uenishi RH, Nakano EY, et al. Assessment of BDNF serum levels as a diagnostic marker in children with autism spectrum disorder. Sci Rep. 2020;10:17348. DOI: 10.1038/s41598-020-74239-x
  7. Pauli-Pott U, Cosan AS, Schloß S, Becker K, Pidcock A, Neumann A, et al. Hair brain-derived neurotrophic factor (BDNF) as predictor of developing psychopathological symptoms in childhood. J Affect Disord. 2023;320:428–35. DOI: 10.1016/j.jad.2022.10.007
  8. Vasileva F, Font-Lladó R, Carreras-Badosa G, López-Ros V, Ferrusola-Pastrana A, López-Bermejo A, et al. Increased salivary BDNF and improved fundamental motor skills in children following a 3-month integrated neuromuscular training in primary school. J Funct Morphol Kinesiol. 2024;9(3):154. DOI: 10.3390/jfmk9030154
  9. Wang YH, Zhou HH, Luo Q, Cui S. The effect of physical exercise on circulating brain-derived neurotrophic factor in healthy subjects: A meta-analysis of randomized controlled trials. Brain Behav. 2022;12(4):e2544. DOI: 10.1002/brb3.2544
  10. Rico-González M, González-Devesa D, Gómez-Carmona CD, Moreno-Villanueva A. Exercise as modulator of brain-derived neurotrophic factor (BDNF) in children: A systematic review of randomized controlled trials. Life. 2025;15(7):1147. DOI: 10.3390/life15071147
  11. Shevchuk SV, Stepaniuk TV. Clinical and diagnostic significance of brain-derived neurotrophic factor in patients with systemic lupus erythematosus, association with disease course and psychoneurological disorders. Ukr Rheumatol J. 2024;98(4):51­–7. DOI: 10.32471/rheumatology.2707-6970.98.19343
  12. Havlovska Y, Lytvynenko N, Shlykova O, Izmailova O, Havlovskyi O, Shkodina A. Neurotrophic factor of the brain as a marker of restoration of motor and cognitive functions in the acute period of cardioembolic and atherothrombotic ischemic stroke. Ukr Sci Med Youth J. 2022;1(128):32–41. DOI: 10.32345/USMYJ.1(128).2022.32-41
  13. Bouhaddou N, Mabrouk M, Atifi F, Bouyahya A, Zaid Y. The link between BDNF and platelets in neurological disorders. Heliyon. 2024;10(21):e39278. DOI: 10.1016/j.heliyon.2024.e39278
  14. World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects [Internet]. [cited 2025 May 23]. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
  15. Goldman J, Becker ML, Jones B, Clements M, Leeder JS. Development of biomarkers to optimize pediatric patient management: What makes children different? Biomark Med. 2011;5(6):781–94. DOI: 10.2217/bmm.11.96
  16. Bothwell M. NGF, BDNF, NT3, and NT4. Handb Exp Pharmacol. 2014;220:3–15. DOI: 10.1007/978-3-642-45106-5_1
  17. Chew JD, Markham L, Smith HM, Su YR, Tomasek K, Slaughter JC, et al. Assessment of brain-derived neurotrophic factor and osteopontin in a healthy pediatric population. J Circ Biomark. 2018;7:1849454418806136. DOI: 10.1177/1849454418806136
  18. Ghassabian A, Sundaram R, Chahal N, McLain AC, Bell E, Lawrence DA, et al. Determinants of neonatal brain-derived neurotrophic factor and association with child development. Dev Psychopathol. 2017;29(4):1499–511. DOI: 10.1017/S0954579417000414
  19. Krey FC, Stocchero BA, Creutzberg KC, Heberle BA, Tractenberg SG, Xiang L, et al. Neurotrophic factor levels in preterm infants: A systematic review and meta-analysis. Front Neurol. 2021;12:643576. DOI: 10.3389/fneur.2021.643576
  20. Mercado L, Rose S, Escalona-Vargas D, Dajani N, Siegel ER, Preissl H, et al. Correlating maternal and cord-blood inflammatory markers and BDNF with human fetal brain activity recorded by magnetoencephalography: An exploratory study. Brain Behav Immun Health. 2024;39:100804. DOI: 10.1016/j.bbih.2024.100804
  21. Dingsdale H, Garay SM, Tyson HR, Savory KA, Sumption LA, Kelleher JS, et al. Cord serum brain-derived neurotrophic factor levels at birth associate with temperament outcomes at one year. J Psychiatr Res. 2022;150:47–53. DOI: 10.1016/j.jpsychires.2022.03.009
  22. Su CH, Liu TY, Chen IT, Ou-Yang MC, Huang LT, Tsai CC, et al. Correlations between serum BDNF levels and neurodevelopmental outcomes in infants of mothers with gestational diabetes. Pediatr Neonatol. 2021;62(3):298–304. DOI: 10.1016/j.pedneo.2020.12.012
  23. Hua J, Williams GJ, Jin H, Chen J, Xu M, Zhou Y, et al. Early motor milestones in infancy and later motor impairments: A population-based data linkage study. Front Psychiatry. 2022;13:809181. DOI: 10.3389/fpsyt.2022.809181
  24. Sarapuk IM, Pavlyshyn HA, Lacina L, Królak-Olejnik B. Neurodevelopmental care of preterm babies and its key elements. Int J Med Med Res. 2017;3(1):26–33. DOI: 10.11603/ijmmr.2413-6077.2017.1.7063
  25. Larsen B, Sydnor VJ, Keller AS, Yeo BTT, Satterthwaite TD. A critical period plasticity framework for the sensorimotor-association axis of cortical neurodevelopment. Trends Neurosci. 2023;46(10):847–62. DOI: 10.1016/j.tins.2023.07.007